Abstract
ADRENOLEUKODYSTROPHY (ALD) is an X-linked disease affecting 1/20,000 males either as cerebral ALD in childhood or as adrenomyeloneuropathy (AMN) in adults1. Childhood ALD is the more severe form, with onset of neurological symptoms between 5–12 years of age. Central nervous system demyelination progresses rapidly and death occurs within a few years. AMN is a milder form of the disease with onset at 15–30 years of age and a more progressive course. Adrenal insufficiency (Addison's disease) may remain the only clinical manifestation of ALD. The principal biochemical abnormality of ALD is the accumulation of very-long-chain fatty acids (VLCFA) because of impaired β-oxidation in peroxisomes1,2. The normal oxidation of VLCFA-CoA in patients' fibroblasts3–5 suggested that the gene coding for the VLCFA-CoA synthetase could be a candidate gene for ALD. Here we use positional cloning to identify a gene partially deleted in 6 of 85 independent patients with ALD. In familial cases, the deletions segregated with the disease. An identical deletion was detected in two brothers presenting with different clinical ALD phenotypes. Candidate exons were identified by computer analysis of genomic sequences6 and used to isolate complementary DNAs by exon connection7 and screening of cDNA libraries. The deduced protein sequence shows significant sequence identity to a peroxisomal membrane protein of Mr 70K that is involved in peroxisome biogenesis and belongs to the ‘ATP-binding cassette’ superfamily of transporters.
Access options
Subscribe to Journal
Get full journal access for 1 year
$199.00
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
from$8.99
All prices are NET prices.
References
- 1
Moser, H. w. & Moser, A. in The Metabolic Basis of Inherited Disease (eds Scriver, C. R., Beaudet, A. L., Sly, W. S. & Valle. D.) 1511–1532 (McGraw-Hill, New York, 1989).
- 2
Singh, I., Moser, A. E., Goldfischer, S. & Moser, H. W. Proc. natn. Acad. Sci. U.S.A. 81, 4203–4207 (1984).
- 3
Hashmi, M., Stanley, W. & Singh, I. FEBS Lett. 196, 247–250 (1986).
- 4
Lazo, O. et al. Proc. natn. Acad. Sci. U.S.A. 85, 7647–7651 (1988).
- 5
Wanders, R. J. A. et al. J. inher. metab. Dis. 11, 173–177 (1988).
- 6
Uberbacher, E. C. & Mural, R. Proc. natn. Acad. Sci. U.S.A. 88, 11261–11265 (1992).
- 7
Fearon, E. R. et al. Science 247, 49–56 (1990).
- 8
Migeon, B. R. et al. Proc. natn. Acad. Sci. U.S.A. 78, 5066–5070 (1981).
- 9
Boué, J. et al. Hum. Genet 69, 272–274 (1985).
- 10
Aubourg, P., Sack, G. H., Meyers, D. A., Lease, J. J. & Moser, H. W. Ann. Neurol. 21, 349–352 (1987)
- 11
Nathans, J., Thomas, D. & Hogness, D. Science 232, 193–202 (1986).
- 12
Sack, G. H., Raven, B. & Moser, H. W. Am. J. hum. Genet. 44, 794–798 (1989).
- 13
Aubourg, P., Sack, G. H. & Moser, H. W. Am. J. hum. Genet. 42, 408–413 (1988).
- 14
Aubourg, P. et al. Am. J. hum. Genet. 46, 459–469 (1990).
- 15
Feil, R. et al. Am. J. hum. Genet. 49, 1361–1371 (1991).
- 16
Kioschis, P. et al. Cytogenet. Cell Genet. 58, 2070 (1991).
- 17
Kamijo, K., Taketani, S., Yokota, S., Osumi, T. & Hashimoto, T. J. biol. Chem. 265, 4534–4540 (1990).
- 18
Kamijo, K., Kamijo, T., Ueno, I., Osumi, T. & Hashimoto, T. Biochim. biophys. Acta 1129, 323–327 (1992).
- 19
Xiao, J. H. Davidson, I., Matthes, H., Garnier, J. M., & Chambon, P. Cell 65, 551–568 (1991).
- 20
Kozak, M. Nucleic Acids Res. 15, 8125–8148 (1987).
- 21
Gärtner, J., Moser, H. & Valle, D. Nature Genet. 1, 16–23 (1992).
- 22
Walker, J. E., Saraste, M., Runswick, M. J. & Gay, N. J. EMBO J 8, 945–951 (1982).
- 23
Suzuki, H. et al. J. biol. Chem. 265, 8681–8685 (1990).
- 24
Roninson, I. B. Molecular and Cellular Biology of Multidrug Resistance in Tumor cells (Plenum, New York, 1991).
- 25
Riordan, J. R. et al. Science 245, 1066–1080 (1989).
- 26
Trowsdale, J. et al. Nature 348, 741–744 (1990).
- 27
Bahram, S., Arnold, D., Bresnahan, M., Strominger, J. L. & Spies, T. Proc natn. Acad. Sci. U.S.A. 88, 10094–10098 (1991).
- 28
Cutting, G. R. et al. Nature 346, 366–369 (1990).
- 29
Higgins, C. F. et al. J. bioenerg. Biomembr. 22, 571–593 (1990).
- 30
Shimozawa, N. et al. Science 255, 1132–1134 (1992).
- 31
Erdmann, R. et al. Cell 64, 499–510 (1991).
- 32
Höhfeld, J., Veenhuis, M. & Kunau, W. H. J. cell Biol. 114, 1167–1178 (1992).
- 33
Imanaka, T., Small, G. M. & Lazarow, P. B. J. cell Biol. 105, 2915–2922 (1987).
- 34
Singh, I., Lazo, O., Dhaunsi, G. S. & Contreras, M. J. biol. Chem. 267, 13306–13313 (1992).
- 35
Sambrook, J., Fritsch, E. F. & Maniatis, T. Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Press, New York, 1989).
- 36
Lipman, D. J. & Pearson, W. R. Science 227, 1435–1441 (1985).
- 37
Gilson, E., Nikaido, H. & Hofnung, M. Nucleic Acids Res. 10, 7449–7458 (1982).
- 38
Moser, H. W. et al. J. inher. metab. Dis. 15, 645–664 (1992).
- 39
Lazarow, P. B. & Moser, H. W. in The Metabolic Basis of Inherited Diseases (eds Scriver, C. R., Beaudet, A. L., Sly, W. S. & Valle, D.) 1479–1509 (McGraw-Hill, New York 1989).
Author information
Affiliations
Rights and permissions
About this article
Cite this article
Mosser, J., Douar, AM., Sarde, CO. et al. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361, 726–730 (1993). https://doi.org/10.1038/361726a0
Received:
Accepted:
Issue Date:
Further reading
-
Generation of a WA14 hESC sub-line carrying a hemizygous ABCD1 (C.1696_1710 del) mutation introduced by CRISPR/Cas9 technology
Stem Cell Research (2021)
-
Evolution of adrenoleukodystrophy model systems
Journal of Inherited Metabolic Disease (2021)
-
Acyl-CoA thioesterase activity of peroxisomal ABC protein ABCD1 is required for the transport of very long-chain acyl-CoA into peroxisomes
Scientific Reports (2021)
-
Generation of an urine-derived induced pluripotent stem cell line from a 6-year old X-linked adrenoleukodystrophy (X-ALD) patient
Stem Cell Research (2021)
-
The functional analysis of ABCG transporters in the adaptation of pigeon pea (Cajanus cajan) to abiotic stresses
PeerJ (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.